 Novan Inc NASDAQ: NOVN has announced positive topline efficacy and safety results from the B-SIMPLE4 Phase 3 trial evaluating SB206, a topical antiviral gel, for the treatment of molluscum contagiosum. Molluscum is a common, contagious skin infection caused by the molluscipoxvirus. 